2023
DOI: 10.3389/fnmol.2022.1098766
|View full text |Cite|
|
Sign up to set email alerts
|

Circulating exosomal microRNA profiles in migraine patients receiving acupuncture treatment: A placebo-controlled clinical trial

Abstract: BackgroundAcupuncture has a long history of being used in Chinese medicine for the treatment of migraine. However, molecular biomarkers for diagnosis and prognosis of migraine and its treatment are lacking. This study aimed to explore whether acupuncture could regulate differentially expressed exosomal miRNAs between patients with migraine without aura (MWoA) and healthy controls (HCs) and to identify diagnostic biomarkers that helped differentiate MWoA patients from HCs and identify prognostic biomarkers that… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 68 publications
0
1
0
Order By: Relevance
“…The three miRNAs: miR-342-5p, miR-532-3p, and miR-758-3p have been proven to present the highest value in migraine diagnosis. The dysregulation of multiple miRNAs was analyzed by another research group (Liu et al 2022 ), which conducted a study on patients suffering from migraine without aura. The results showed 68 upregulated and 104 downregulated miRNAs as compared to healthy controls, which may be considered as potential biomarkers.…”
Section: Micrornas In Patients Suffering From Migrainementioning
confidence: 99%
“…The three miRNAs: miR-342-5p, miR-532-3p, and miR-758-3p have been proven to present the highest value in migraine diagnosis. The dysregulation of multiple miRNAs was analyzed by another research group (Liu et al 2022 ), which conducted a study on patients suffering from migraine without aura. The results showed 68 upregulated and 104 downregulated miRNAs as compared to healthy controls, which may be considered as potential biomarkers.…”
Section: Micrornas In Patients Suffering From Migrainementioning
confidence: 99%